Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer

Irinotecan and cisplatin demonstrated promising outcomes in extensive-stage small-cell lung cancer. According to the dosage and schedule of irinotecan, efficacy and toxicity profiles showed subtle differences. This study was designed to evaluate efficacy and toxicity of 3-week schedule of irinotecan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hong, Y S, Lee, H R, Park, S, Lee, S C, Hwang, I G, Park, B-B, Lee, J, Ahn, J S, Ahn, M-J, Lim, H Y, Park, K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360764/
https://ncbi.nlm.nih.gov/pubmed/17133266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603500
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados